-
Correction to Lancet Glob Health 2025; 13: e112-20. Lancet Global Health (IF 19.9) Pub Date : 2025-02-07
-
Action towards connecting knowledge translation and implementation research. Lancet Global Health (IF 19.9) Pub Date : 2025-02-07 Olivia Biermann,Meike Schleiff,Davi Mamblona Marques Romao,Carolina Mikaelsdotter,Tobias Alfvén,Rhoda K Wanyenze,Stefan Swartling Peterson,Tanja Kuchenmüller
-
Correction to Lancet Glob Health 2025; 13: e345-54. Lancet Global Health (IF 19.9) Pub Date : 2025-02-06
-
Automated oxygen control for preterm infants receiving continuous positive airway pressure in southwest Nigeria: an open-label, randomised, crossover trial Lancet Global Health (IF 19.9) Pub Date : 2025-01-29 Rami Subhi MBBS, Lachlann McLeod BEng, Adejumoke Idowu Ayede MBBS, Iyabode Olabisi Dedeke MBBS, Quadri Risikat RN, Alao Ridwan Akanbi RN, Adeola Baliqis Fasasi RN, Ayobami A Bakare MBBS, Oluwatosin Helen Adeniyi MBBS, Olugbenga Akinrinoye MSc, Olanrewaju Adeigbe MBBS, George F Dargaville MPH, Patrick Walker MBBS, Anneke C Grobler PhD, Olufunke Mosebolatan RN, Shiraz Badurdeen PhD, Timothy J Gale PhD
Titration of oxygen therapy to target safe oxygen saturation (SpO2) values is a vital part of care for preterm infants, but is difficult to achieve, particularly in settings in which oxygen, monitoring technology, and human resources are scarce. We aimed to evaluate the safety and efficacy of automated titration of oxygen therapy partnered with a low-cost continuous positive airway pressure (CPAP)
-
24-week, all-oral regimens for pulmonary rifampicin-resistant tuberculosis in TB-PRACTECAL trial sites: an economic evaluation Lancet Global Health (IF 19.9) Pub Date : 2025-01-29 Sedona Sweeney PhD, Yoko V Laurence PhD, Catherine Berry BMed, Maninder Pal Singh MPH, Matthew Dodd PhD, Prof Katherine Fielding PhD, Emil Kazounis MMedSci, Ronelle Moodliar MMed, Varvara Solodovnikova MD, Zinaida Tigay MD, Prof Irina Liverko DSc, Prof Nargiza Parpieva DS, Ilhomjon Butabekov MS, Ruzilya Usmanova MClinSci, Mohammed Rassool MBChB, Ilaria Motta PhD, George Mokua Nyangweso BSc, Pascal
New 6-month rifampicin-resistant tuberculosis treatment regimens containing bedaquiline, pretomanid, and linezolid (BPaL) with or without moxifloxacin or clofazimine, could improve treatment efficacy, safety, and tolerability, and free up resources within the health system. Following a change to WHO rifampicin-resistant tuberculosis treatment guidelines, countries are facing difficult decisions about
-
Causes of HIV-related CNS infection in Cameroon, Malawi, and Tanzania: epidemiological findings from the DREAMM HIV-related CNS implementation study Lancet Global Health (IF 19.9) Pub Date : 2025-01-29 Cecilia Kanyama MD, Charles Kouanfack PhD, Saulos Nyirenda MD, Prof Sayoki Mfinanga MD, Sokoine Lesikari Kivuyo MD, Emma Beaumont MSc, Aude Sturny-Leclère MSc, Prof Sam Phiri PhD, Jonathon Ngoma MD, Meshack Shimwela MD, Daniel Nkungu MMed, Lauriane Nomene Fomete MD, Rehema Simbauranga MD, Chimwemwe Chawinga BSc, Nicaine Ngakam MD, Tom Heller MD, Sandrine Sa'a Lontsi MD, Rebecca Gathercole MSc, Elnara
CNS infections cause approximately a third of HIV-related deaths. The Driving Reduced AIDS-Associated Meningo-encephalitis Mortality DREAMM study aimed to prospectively diagnose the aetiology of HIV-related CNS infection in five public hospitals in Cameroon, Malawi, and Tanzania.
-
Early detection and a treatment bundle strategy for postpartum haemorrhage: a mixed-methods process evaluation Lancet Global Health (IF 19.9) Pub Date : 2025-01-29 Prof Meghan A Bohren PhD, Prof Suellen Miller PhD, Kristie-Marie Mammoliti MSc, Prof Hadiza Galadanci FRCOG, Prof Sue Fawcus FRCOG, Neil Moran BM BCh, Prof G Justus Hofmeyr DSc, Zahida Qureshi MMed, Fadhlun Alwy Al-Beity PhD, Gillian Forbes PhD, Shahinoor Akter PhD, Alfred Osoti PhD, George Gwako PhD, Thiago Melo Santos PhD, Cherrie Evans DrPH, Aminu Ado Wakili MBBS, Maisaratu Bakari FWACS, Idris Usman
Postpartum haemorrhage is a leading cause of maternal mortality. A multicountry, cluster-randomised trial (E-MOTIVE) demonstrated a 60% reduction in adverse postpartum haemorrhage outcomes. The E-MOTIVE intervention included early postpartum haemorrhage detection using calibrated blood-collection drapes, followed by a postpartum haemorrhage treatment bundle (ie, uterine massage, oxytocics, tranexamic
-
Scarcity of research on breastfeeding and Ebola diseases is placing the lives of women and infants at risk: a call to specific action Lancet Global Health (IF 19.9) Pub Date : 2025-01-29 Prof Catriona Waitt PhD, Karleen Gribble PhD, Peter Waitt FRCP, Prince Imani-Musimwa MD, Christine Liang MPH, Mija Ververs MMed
Ebola virus outbreaks causing viral haemorrhagic fever occur predominantly in regions with high fertility, where breastfeeding is the only safe infant feeding option. Yet, there is a dearth of evidence to inform recommendations and decision making for breastfeeding mothers. Specific gaps in knowledge include whether or for how long replicable virus is present in breastmilk, whether mother-to-infant
-
Associations between childhood trauma and adolescent psychiatric disorders in Brazil: a longitudinal, population-based birth cohort study Lancet Global Health (IF 19.9) Pub Date : 2025-01-29 Megan Bailey MSc, Graeme Fairchild PhD, Gemma Hammerton PhD, Andreas Bauer PhD, Marina X Carpena PhD, Joseph Murray PhD, Ina S Santos PhD, Aluísio J D Barros PhD, Luciana Tovo-Rodrigues PhD, Andrea Danese MD, Sarah L Halligan PhD, Alicia Matijasevich PhD
The mental health consequences of exposure to childhood trauma have been little studied among adolescents in low-income and-middle-income countries (LMICs), despite a relatively high burden of trauma in LMIC populations. We investigated associations between trauma and adolescent psychiatric disorders in the 2004 Pelotas Birth Cohort, Brazil.
-
Emergence and spread of the SARS-CoV-2 omicron (BA.1) variant across Africa: an observational study Lancet Global Health (IF 19.9) Pub Date : 2025-01-29 Carlo Fischer MSc, Tongai Gibson Maponga PhD, Anges Yadouleton PhD, Nuro Abílio BSc, Emmanuel Aboce MSc, Praise Adewumi MSc, Pedro Afonso MSc, Jewelna Akorli PhD, Soa Fy Andriamandimby PhD, Latifa Anga PhD, Yvonne Ashong MPhil, Mohamed Amine Beloufa PhD, Aicha Bensalem MD, Prof Richard Birtles PhD, Prof Anicet Luc Magloire Boumba PhD, Freddie Bwanga PhD, Mike Chaponda MD, Paradzai Chibukira MSc, R
In mid-November, 2021, the SARS-CoV-2 omicron variant (B.1.1.529; BA.1 sublineage) was detected in southern Africa, prompting international travel restrictions. We aimed to investigate the spread of omicron BA.1 in Africa.
-
Durability of immunogenicity at 5 years after a single dose of human papillomavirus vaccine compared with two doses in Tanzanian girls aged 9–14 years: results of the long-term extension of the DoRIS randomised trial Lancet Global Health (IF 19.9) Pub Date : 2025-01-29 Prof Deborah Watson-Jones PhD, John Changalucha MSc, Caroline Maxwell MSc, Hilary Whitworth PhD, Paul Mutani MD, Troy J Kemp PhD, Beatrice Kamala Dip, Jackton Indangasi MSc, George Constantine MD, Ramadhan Hashim BSc, David Mwanzalima BSc, Rebecca Wiggins PhD, Devis Mmbando BSc, Nicholas Connor MSc, Miquel A Pavon PhD, Brett Lowe MSc, Prof Saidi Kapiga MD PhD, Prof Philippe Mayaud MD, Silvia de Sanjosé
WHO has recommended that one dose of human papillomavirus (HPV) vaccine can be given to individuals aged 9–20 years to prevent HPV infection. Estimating durability of immune responses after a single dose in the target age for vaccination is important. We report immunogenicity results in Tanzanian girls up to 5 years after receiving a dose.
-
Social and health disparities associated with healthy brain ageing in Brazil and in other Latin American countries Lancet Global Health (IF 19.9) Pub Date : 2025-01-29 Lucas U Da Ros MD, Wyllians Vendramini Borelli PhD, Cristiano Schaffer Aguzzoli MD, Marco Antônio De Bastiani PhD, Lucas Porcello Schilling PhD, Hernando Santamaria-Garcia PhD, Prof Tharick A Pascoal PhD, Prof Pedro Rosa-Neto PhD, Prof Diogo O Souza MD PhD, Prof Jaderson Costa da Costa PhD, Prof Agustin Ibañez PhD, Claudia Kimie Suemoto MD, Eduardo R Zimmer PhD
Latin American countries present major health-related inequities due to historical, cultural, and social aspects. Recent evidence highlights that factors related to social and health disparities outweigh classic demographic factors in determining healthy brain aging in these populations. However, these analyses have not been conducted with the Brazilian population, the largest and most ethnically diverse
-
Epidemiology of menstrual-related absenteeism in 44 low-income and middle-income countries: a cross-sectional analysis of Multiple Indicator Cluster Surveys Lancet Global Health (IF 19.9) Pub Date : 2025-01-29 Miranda Starr BSc MPH, Rebecca Harding PhD, Ricardo Ataíde PhD, Naomi Von Dinklage MPH, Sheela S Sinharoy PhD, Yasmin Jayasinghe PhD, Lucinda Manda-Taylor PhD, Prof Jane Fisher PhD, Sabine Braat MSc, Prof Sant-Rayn Pasricha PhD
Menstrual-related absenteeism from work, school, or social activities is an important functional indicator of poor menstrual health that disrupts women's and girls’ daily lives and exacerbates gender inequality. We sought to estimate the prevalence of and factors contributing to menstrual-related absenteeism across low-income and middle-income countries.
-
The effects of prenatal multiple micronutrient supplementation and small-quantity lipid-based nutrient supplementation on small vulnerable newborn types in low-income and middle-income countries: a meta-analysis of individual participant data Lancet Global Health (IF 19.9) Pub Date : 2025-01-29 Dongqing Wang PhD, Enju Liu PhD, Nandita Perumal PhD, Uttara Partap PhD, Ilana R Cliffer PhD, Janaína Calu Costa PhD, Molin Wang PhD, Prof Wafaie W Fawzi DrPH, Gestational Weight Gain Pooling Project Consortium, Seth Adu-Afarwuah, Per Ashorn, Ulla Ashorn, Malay Kanti Mridha, Shams Arifeen, Zulfiqar A Bhutta, Yue Cheng, Parul Christian, Anthony M Costello, Kathryn G Dewey, Henrik Friis, Exnevia Gomo
Small vulnerable newborn types, defined by combinations of being born too soon or too small, have distinct determinants and health consequences. We aimed to assess the effects of prenatal multiple micronutrient supplementation (MMS) and small-quantity lipid-based nutrient supplementation (SQ-LNS) on small vulnerable newborn types, which are currently unknown.
-
Variability and social patterning of cancer mortality in 343 Latin American cities: an ecological study Lancet Global Health (IF 19.9) Pub Date : 2025-01-29 Tania Alfaro MD, Kevin Martinez-Folgar PhD, Dalia Stern PhD, Maria A Wilches-Mogollon PhD, María Pía Muñoz MPH, Harrison Quick PhD, Marcio Alazraqui PhD, Manuel Ramirez-Zea PhD, J Jaime Miranda MD, Mariana Lazo PhD, Waleska Teixeira Caiaffa PhD, Ana V Diez Roux PhD, Usama Bilal PhD
Understanding between-city variations in cancer mortality is crucial to inform national and subnational cancer prevention strategies. However, studies at the city level in Latin America are scarce. As part of the Salud Urbana en América Latina (SALURBAL) project, we aimed to describe the variability in cancer mortality rates across 343 cities in nine Latin American countries and the associations of
-
The prevalence of hypoxaemia in paediatric and adult patients in health-care facilities in low-income and middle-income countries: a systematic review and meta-analysis Lancet Global Health (IF 19.9) Pub Date : 2025-01-29 Hamish R Graham PhD, Esrat Jahan MBBS, Rami Subhi MPH, Farhia Azrin MS, Jaclyn R Maher MD, Jasmine L Miller MA, Ahmed Ehsanur Rahman PhD, Felix Lam MS
Hypoxaemia (low oxygen saturation in blood) is a key predictor of in-hospital mortality, affecting people of all ages with many different conditions. Early detection and treatment of hypoxaemia are critical, but there are few data to quantify hypoxaemia burden outside the child pneumonia population. We aimed to estimate hypoxaemia prevalence for adults and children with acute illness attending health
-
Effectiveness of 2023 southern hemisphere influenza vaccines against severe influenza-associated illness: pooled estimates from eight countries using the test-negative design Lancet Global Health (IF 19.9) Pub Date : 2025-01-29 Radhika Gharpure DVM, Annette K Regan PhD, Francisco Nogareda MPH, Prof Allen C Cheng PhD, Prof Christopher C Blyth PhD, Siobhan St George MPhil, Q Sue Huang PhD, Tim Wood MA, Andrew Anglemyer PhD, Kriengkrai Prasert MD, Prabda Praphasiri DrPH, William W Davis DrPH, Chakrarat Pittayawonganon MD, Regina Ercole Mg, Analia Iturra BS, Walquiria Aparecida Ferreira de Almeida PhD, Francisco José de Paula
Annual estimates of seasonal influenza vaccine effectiveness can guide global risk communication and vaccination strategies to mitigate influenza-associated illness. We aimed to evaluate vaccine effectiveness in countries using the 2023 southern hemisphere influenza vaccine formulation.
-
Prevalence, aetiology, and hospital outcomes of paediatric acute critical illness in resource-constrained settings (Global PARITY): a multicentre, international, point prevalence and prospective cohort study Lancet Global Health (IF 19.9) Pub Date : 2025-01-29 Teresa B Kortz MD, Adrian Holloway MD, Asya Agulnik MD, David He MS, Stephanie Gordon Rivera MPH, Qalab Abbas MBBS, John Adabie Appiah MD, Anita V Arias MD, Jonah Attebery MD, Prof Jhon Camacho-Cruz MD, Paula Caporal MD, Karla Emilia de Sa Rodrigues PhD, Ericka Fink MD, Niranjan Kissoon MBBS, Jan Hau Lee MBBS, Prof Eliana López-Barón MD, Srinivas Murthy MD, Fiona Muttalib MDCM, Katie Nielsen MD, Kenneth
Children in resource-constrained settings (RCS) have disproportionately high illness and mortality; however, the prevalence in RCS of paediatric acute critical illness (P-ACI; life-threatening conditions that require time-sensitive interventions) is unknown. Most P-ACI can be managed with basic critical care (stabilisation, fluid resuscitation, oxygen, and vital-organ support), but RCS hospitals often
-
2022 Sudan virus disease outbreak in Uganda: temporal variations in transmission Lancet Global Health (IF 19.9) Pub Date : 2025-01-29 Bianca de Padua, Andrei R Akhmetzhanov, Robin N Thompson
-
Lessons for future implementation of the E-MOTIVE bundle Lancet Global Health (IF 19.9) Pub Date : 2025-01-29 Jill Durocher, Sam Ononge
-
Is now the time for revisiting supplements for pregnant women? Lancet Global Health (IF 19.9) Pub Date : 2025-01-29 Jai K Das, Natasha Lelijveld
-
The need for epidemiological data on HIV-related CNS infections in low-income and middle-income settings Lancet Global Health (IF 19.9) Pub Date : 2025-01-29 Regan Solomons, Helena Rabie
-
The continuum of menstrual health through the life course Lancet Global Health (IF 19.9) Pub Date : 2025-01-29 Tamaryn L Crankshaw, Nontsikelelo Manzini-Matebula
-
Cancer plans should consider local needs Lancet Global Health (IF 19.9) Pub Date : 2025-01-29 Bettina Müller, Raul Murillo
-
The era of no review: an appraisal on transparency in global health funding Lancet Global Health (IF 19.9) Pub Date : 2025-01-29 Christine Ngaruiya, Calvin Omolo
-
Travel bans did not contain omicron: a call for data-driven public health responses Lancet Global Health (IF 19.9) Pub Date : 2025-01-29 Esayas Kebede Gudina, Netsanet Workneh Gidi
-
Climate change and NTDs: a perfect storm Lancet Global Health (IF 19.9) Pub Date : 2025-01-29 The Lancet Global Health
-
Harnessing the power of multicountry networks for influenza vaccine monitoring Lancet Global Health (IF 19.9) Pub Date : 2025-01-29 Cecile Viboud, Kathleen M Neuzil
-
Care for children with critical illness: a global public health need Lancet Global Health (IF 19.9) Pub Date : 2025-01-29 Mohammod Jobayer Chisti, Trevor Duke
-
Eliminate prescribers' uncertainty to catalyse the impact of vaccines on antibiotic use. Lancet Global Health (IF 19.9) Pub Date : 2025-01-28 Brecht Ingelbeen,Nandini Sreenivasan,Annick Lenglet
-
Tuberculosis and people who use drugs: why focus on this overlooked population is important and why adapted interventions are necessary. Lancet Global Health (IF 19.9) Pub Date : 2025-01-22 Morgana D'Ottavi,Peter Godfrey-Faussett,Corinne S Merle,Mircea T Sofonea,Didier Laureillard,Peter Vickerman,Jean-Pierre Molès,Frederick L Altice,Philippe Van de Perre,Jack Stone,Nicolas Nagot
People who use drugs show a higher incidence and prevalence of tuberculosis than people who do not use drugs in areas where Mycobacterium tuberculosis is endemic. However, this population is largely neglected in national tuberculosis programmes. Strategies for active case finding, screening, and linkage to care designed for the general population are not adapted to the needs of people who use drugs
-
The climate crisis and human health: identifying grand challenges through participatory research Lancet Global Health (IF 19.9) Pub Date : 2025-01-21 J Johanna Sanchez, Evelyn Gitau, Reda Sadki, Charlotte Mbuh, Karlee Silver, Climate and Health Expert Panel, Peter Berry, Zulfiqar Bhutta, Kimber Bogard, Gwen Collman, Sagnik Dey, Tufa Dinku, Ni Made Utami Dwipayanti, Kristie Ebi, Monica Felts La Roca Soares, Masilin Gudoshava, Masahiro Hashizume, Maureen Lichtveld, Rachel Lowe, Bilal Mateen, Martin Muchangi, Ousmane Ndiaye, Paulino Omay, Wellington
-
Payment in arrears: a global health inequity that must be corrected. Lancet Global Health (IF 19.9) Pub Date : 2025-01-20 Kirchuffs Atengble,Rifat Atun,Lydia Aziato,Frank Baiden,Jessica L Boxall,Margaret Gyapong,Michael G Head,Victor Mogre,Pathik Pathak,Julie Reeves
-
Rethinking pandemic metrics: are composite indices enough? Lancet Global Health (IF 19.9) Pub Date : 2025-01-17 Clara Marín-Carballo,Bach Tran,Shenglan Tang,Michael Merson,Taufique Joarder
-
Strengthening nutritional care to end tuberculosis in India. Lancet Global Health (IF 19.9) Pub Date : 2025-01-14 Nandini Sharma,Saurav Basu
-
Estimating the epidemiological and economic impact of providing nutritional care for tuberculosis-affected households across India: a modelling study. Lancet Global Health (IF 19.9) Pub Date : 2025-01-14 Christopher Finn McQuaid,Rebecca A Clark,Richard G White,Roel Bakker,Peter Alexander,Roslyn Henry,Banurekha Velayutham,Malaisamy Muniyandi,Pranay Sinha,Madhavi Bhargava,Anurag Bhargava,Rein M G J Houben
BACKGROUND Approximately 20% of global tuberculosis incidence is attributable to undernutrition, increasing to more than a third in India. Targeting nutritional interventions to tuberculosis-affected households is a policy priority, but understanding of epidemiological and economic impacts is limited. We aimed to estimate the population-level epidemiological and economic effect of such an intervention
-
Monitoring essential medicines access—unfinished business Lancet Global Health (IF 19.9) Pub Date : 2024-12-18 Andrew Lofts Gray, Fatima Suleman
-
Menopause: a global health and wellbeing issue that needs urgent attention Lancet Global Health (IF 19.9) Pub Date : 2024-12-18 Gayathri Delanerolle, Peter Phiri, Sohier Elneil, Vikram Talaulikar, George U Eleje, Rabia Kareem, Ashish Shetty, Lucky Saraswath, Om Kurmi, Cristina Laguna Benetti-Pinto, Ifran Muhammad, Nirmala Rathnayake, Teck-Hock Toh, Ieera Madan Aggarwal, Jian Qing Shi, Julie Taylor, Kathleen Riach, Kristina Potocnik, Ian Litchfield, Helen Felicity Kemp, Paula Briggs, the MARIE collaborative, Vindya Pathiraja
-
Relapse after recovery from acute malnutrition Lancet Global Health (IF 19.9) Pub Date : 2024-12-18 Lilia Bliznashka
-
Association of current Schistosoma mansoni, Schistosoma japonicum, and Schistosoma mekongi infection status and intensity with periportal fibrosis: a systematic review and meta-analysis Lancet Global Health (IF 19.9) Pub Date : 2024-12-18 Adanna Ewuzie MSc, Lauren Wilburn PhD, Dixa B Thakrar MRCS, Huike Cheng MSc, Fabian Reitzug MSc, Nia Roberts PhD, Reem Malouf MD, Goylette F Chami PhD
Periportal fibrosis is a severe morbidity caused by both current and past exposure to intestinal schistosomes. We aimed to assess the association between current infection status and intensity of Schistosoma mansoni, Schistosoma japonicum, or Schistosoma mekongi with periportal fibrosis.
-
Safety and immunogenicity of an acellular pertussis vaccine containing genetically detoxified pertussis toxin administered to pregnant women living with and without HIV and their newborns (WoMANPOWER): a randomised controlled trial in Uganda Lancet Global Health (IF 19.9) Pub Date : 2024-12-18 Eve Nakabembe MD, Melanie Greenland MSc, Kyle Amaral MSc, Bahaa Abu-Raya PhD, Alexander Amone MPH, Nick Andrews PhD, Liberty Cantrell MSc, Elodie Lesne PhD, Andrew Gorringe PhD, Rachel Halkerston PhD, Nikki Mcstraw MRes, Louisa Dixon BSc, Olivia F Hunter BA, Paul T Heath FRCPCH, Esther Imede MLS, Mary Kyohere MSc, Philippa Musoke PhD, Annettee Nakimuli PhD, Musa Sekikubo PhD, Stephen Taylor PhD, Valerie
Immunisation in pregnancy against pertussis can reduce severe disease in infancy. There are few data on the safety and immunogenicity of vaccines given to pregnant women living with HIV and their infants. We aimed to describe the safety and immunogenicity of a tetanus–diphtheria–acellular pertussis (TdaP) vaccine containing genetically detoxified pertussis toxin given to pregnant women living with
-
Global burden of tuberculous meningitis in children aged 0–14 years in 2019: a mathematical modelling study Lancet Global Health (IF 19.9) Pub Date : 2024-12-18 Karen du Preez PhD, Helen E Jenkins PhD, Leonardo Martinez PhD, Silvia S Chiang MD, Sicelo S Dlamini MPH, Mariia Dolynska PhD, Andrii Aleksandrin PhD, Julia Kobe MA, Prof Stephen M Graham PhD, Prof Anneke C Hesseling PhD, Prof Jeffrey R Starke MD, Prof James A Seddon PhD, Prof Peter J Dodd PhD
Tuberculous meningitis is fatal if untreated and can lead to lifelong neurological sequelae. However, to our knowledge, there are no data on the number of children affected by this disease. We aimed to estimate the global disease burden and attributable mortality of childhood tuberculous meningitis by WHO regions, age groups, treatment status, and HIV status in 2019.
-
Rates and risk factors for relapse among children recovered from severe acute malnutrition in Mali, South Sudan, and Somalia: a prospective cohort study Lancet Global Health (IF 19.9) Pub Date : 2024-12-18 Sarah King MPH, Anastasia Marshak PhD, Lauren D’Mello-Guyett PhD, Ellyn Yakowenko MA, Sherifath Mama Chabi PhD, Salimata Samake MD, Magloire Bunkembo MPH, Samou Diarra DES, Feysal Abdisalan Mohamud MPH, Mohamed Sheikh Omar MPH, Nancy Grace Lamwaka PgD, Mesfin Gose MSc, Khamisa Ayoub BA, Ahmed Hersi Olad, Aliou Bagayoko MD, Indi Trehan MD MPH, Oliver Cumming MSc, Heather Stobaugh PhD
Community-based management of acute malnutrition is an effective treatment model for severe acute malnutrition. However, sparse evidence exists on post-discharge outcomes and the sustainability of recovery. This study aimed to evaluate the risk and determinants of relapse following severe acute malnutrition recovery in high-burden settings.
-
Prices, availability, and affordability of adult medicines in 54 low-income and middle-income countries: evidence based on a secondary analysis Lancet Global Health (IF 19.9) Pub Date : 2024-12-18 Lachlan Oldfield MSc, Jonathan Penm PhD, Ardalan Mirzaei PhD, Prof Rebekah Moles PhD
Medication shortages are a pressing concern throughout the world. To gain insight into this issue, WHO and Health Action International (HAI) have constructed a validated method to survey medicine prices, availability, and affordability in low-income and middle-income countries. This paper aims to present an updated analysis of medicine affordability, availability, and pricing across 54 countries using
-
Progress in reducing socioeconomic inequalities in the use of modern contraceptives in 48 focus countries as part of the FP2030 initiative between 1990 and 2020: a population-based analysis Lancet Global Health (IF 19.9) Pub Date : 2024-12-18 Carolina Cardona PhD, Jean Christophe Rusatira MD, Carolina Salmeron MPH, Michelle Martinez-Baack MSPH, Jose G Rimon MA, Philip Anglewicz PhD, Saifuddin Ahmed PhD
Despite increases in modern contraception use, socioeconomic inequalities in family planning persist. In this study, we aimed to measure progress in reducing socioeconomic inequalities in modern contraceptive prevalence rate (mCPR) and demand for family planning satisfied by modern methods (mDFPS) in 48 countries as part of the Family Planning 2030 (FP2030) initiative between 1990 and 2020 for which
-
Mifepristone–misoprostol intervals: insights into the timing of abortion Lancet Global Health (IF 19.9) Pub Date : 2024-12-18 Somayeh Makvandi
-
Distinguishing between mortality rates for heart failure with preserved versus reduced ejection fraction Lancet Global Health (IF 19.9) Pub Date : 2024-12-18 Haoyi Zheng
-
Global primary care: what it is, what it isn’t, and why it matters to us all Lancet Global Health (IF 19.9) Pub Date : 2024-12-18 Luke N Allen, Michael Kidd
-
Improving access to liposomal amphotericin B worldwide Lancet Global Health (IF 19.9) Pub Date : 2024-12-18 Antonio Flores, Diego R Falci
-
Improving access to liposomal amphotericin B worldwide – Authors’ reply Lancet Global Health (IF 19.9) Pub Date : 2024-12-18 Janice Soo Fern Lee, Omar Sued, Isabela Ribeiro, Joseph N Jarvis, Jessica Burry
-
Improving access to liposomal amphotericin B worldwide Lancet Global Health (IF 19.9) Pub Date : 2024-12-18 Manoj Jadhav, Jitendra N Verma, Nilima A Kshirsagar
-
Double stigma among pregnant adolescents living with HIV in sub-Saharan Africa: a call to action Lancet Global Health (IF 19.9) Pub Date : 2024-12-18 Ronald Olum, Noeline Nakasujja, Elvin Geng
-
An innovative Community Mobilisation and Community Incentivisation for child health in rural Pakistan (CoMIC): a cluster-randomised, controlled trial Lancet Global Health (IF 19.9) Pub Date : 2024-12-18 Jai K Das PhD, Rehana A Salam PhD, Zahra Ali Padhani MSc, Arjumand Rizvi MS, Mushtaq Mirani MSc, Muhammad Khan Jamali MSc, Imran Ahmed Chauhadry MSc, Imtiaz Sheikh MSc, Sana Khatoon MS, Khan Muhammad MSc, Rasool Bux MSc, Anjum Naqvi MS, Fariha Shaheen MSc, Rafey Ali MS, Sajid Muhammad MS, Prof Simon Cousens DipMAthStat, Prof Zulfiqar A Bhutta PhD
Infectious diseases remain the leading cause of death among children younger than 5 years due to disparities in access and acceptance of essential interventions. The Community Mobilisation and Community Incentivisation (CoMIC) trial was designed to evaluate a customised community mobilisation and incentivisation strategy for improving coverage of evidence-based interventions for child health in Pakistan
-
Effectiveness and acceptability of a 24-h interval versus a 48-h interval between mifepristone intake and misoprostol administration for in-hospital abortion at 9–20 gestational weeks: an international, open-label, randomised, controlled, non-inferiority trial Lancet Global Health (IF 19.9) Pub Date : 2024-12-18 Margit Endler MD PhD, Prof Unnop Jaisamrarn MD MHSc, Prof Suneeta Mittal MD, Phutrakool Phanupong PhD, Vu Van Du MD PhD, Toan Anh Ngo MD PhD, Hans Vemer MD PhD, A Metin Gülmezoglu MD PhD, Prof Kristina Gemzell-Danielsson MD PhD
Optimising management of second-trimester medical abortion is important, as complications increase with gestational age. We aimed to compare a 24-h interval with a 48-h interval between mifepristone intake and misoprostol administration in in-hospital, second-trimester medical abortion for effectiveness and acceptability.
-
Contraceptive equity: insights from the progress in 48 FP2030 countries Lancet Global Health (IF 19.9) Pub Date : 2024-12-18 Ndema Habib, Moazzam Ali
-
Essential shifts in health workforce measurement: a human-centred approach Lancet Global Health (IF 19.9) Pub Date : 2024-12-18 Pooja Yerramilli MD, Kathryn Andrews ScD, Jigyasa Sharma ScD, Mickey Chopra PhD
The health sector has faced long-standing challenges in drivers of worker behaviours and performance, such as job satisfaction, which have been worsened by COVID-19. Structural issues including high workloads and poor working conditions have long contributed to dissatisfaction among health workers. The pandemic escalated unsafe working conditions, causing workers’ deaths, increasing burnout rates,
-
Metrics for access to water and sanitation need structural changes Lancet Global Health (IF 19.9) Pub Date : 2024-12-18 Anoop Jain, S V Subramanian
-
Community mobilisation and incentives for child health Lancet Global Health (IF 19.9) Pub Date : 2024-12-18 Mira Johri
-
Contextual factors influencing bubble continuous positive airway pressure implementation for paediatric respiratory distress in low-income and middle-income countries: a realist review Lancet Global Health (IF 19.9) Pub Date : 2024-12-12 Nadir Ijaz MD MHS, Marie Nader MD, Matthew Ponticiello BS, Ashlee J Vance PhD RN, Brittney J van de Water PhD CPNP, Melissa C Funaro MS MLS, Qalab Abbas MBBS, John Adabie Appiah MD FWACP, Mohammod Jobayer Chisti MBBS PhD, Prof Walter Commerell PhD, Suiyven Elvis Dzelamunyuy MSN, Rudimar Martinez Fernandez RRT, Prof Anjelica L Gonzalez PhD, Prof Cintia Johnston RRT PhD, Evance Luckson Kaiwe BSN, Manjinder
Bubble continuous positive airway pressure (bCPAP) is a low-cost, non-invasive respiratory support therapy for children with respiratory distress, but its effectiveness is dependent on the context. We aimed to understand contextual factors influencing bCPAP implementation for children aged 1–59 months in low-income and middle-income countries (LMICs) and to develop a theory explaining how these factors
-
Using theory to understand how interventions work and inform future implementation Lancet Global Health (IF 19.9) Pub Date : 2024-12-12 Hamish R Graham, Jacquie Oliwa